comparemela.com

Latest Breaking News On - மார் பசேலியோஸ் மருத்துவ பணி மருத்துவமனை - Page 1 : comparemela.com

487 new cases as testing drops in Ernakulam

487 new cases as testing drops in Ernakulam Updated: Updated: Share Article AAA The district recorded 487 new COVID-19 cases on Monday, while testing dropped to 3,507 samples. Five health workers have newly tested positive. Maradu recorded 44 new cases, while Thuravoor, Thrikkakara and Thripunithura registered 17 each. With 616 recoveries on Monday, the active caseload stands at 10,767. A majority of people (8,709) are recovering at home, while 75 patients are admitted at the PVS Hospital, 45 at the Government Medical College Hospital and 820 at private hospitals. Vaccination At 19 centres in the district, 1,796 health workers took the Covishield shot on Monday. While 156 health workers were inoculated at the MOSC Medical College Hospital, 116 took the injection at Aster Medcity, 111 at the Ernakulam General Hospital, 102 at Amrita Hospital, and 100 at the Mar Baselios Medical Mission Hospital. Vaccination also began at PVS Hospital, where 84 health workers took the vaccine

442 administered Covishield on second day in district

442 administered Covishield on second day in district Updated: Updated: Vaccination centres to be opened at Muvattupuzha, Karuvelipady, Paravur Share Article Vaccination centres to be opened at Muvattupuzha, Karuvelipady, Paravur On Monday, the second day of vaccination for COVID-19 in the district, 442 of the targeted 636 health workers took the Covishield vaccine at eight centres. Small snags on the CoWIN app, which had prevented messages from being sent out to vaccine recipients on Saturday informing them of the time and place of vaccination, had been resolved and the system worked faster on the second day, Dr. Sivadas M.G., nodal officer for vaccination, said. Some people, who received the vaccine on Saturday and reported myalgia or body pain, had recovered, and no serious adverse reactions were reported.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.